Lipid/Metabolic
"Extreme" obesity carries higher mortality risk than lower levels of obesity
July 4, 2006 | Shelley Wood

As increasing numbers of Americans become more obese than ever before, mortality and health-expenditure estimates may need to be revised to reflect the fact that as obesity levels rise, so does the risk of dying or developing coronary heart disease. Researchers writing in the July 5, 2006 issue of the Journal of the American Medical Association report that women with "extreme obesity" (BMI >40) have a greater mortality risk than women with lesser degrees of obesity [1].

"Considering obesity as a homogenous condition with fixed risk is inappropriate," Dr Kathleen McTigue (University of Pittsburgh, PA) et al write. "Weight-related health risk clearly varies with degree of excess weight."

As McTigue et al note, "obesity" refers to a BMI of 30 or greater; however, it can also be further defined by category—obesity 1 (BMI 30-34.9), obesity 2 (35-49.9), and obesity 3 (>40). "The latter two, sometimes termed severe obesity, are reported to be increasing, especially rapidly in the US," McTigue et al write.


The fat get fatter

For their study, McTigue et al used data from more than 90 000 women, aged 50 to 79 years, participating in the Women's Health Initiative—Observational Study. Event rates were tracked over a seven-year period.

Overall deaths, expressed as rate per 10 000 person-years, was 68.39 for normal-weight women—similar to that of overweight women. These rates, however, continued to increase across all three levels of obesity and were highest among the women with extreme obesity.

Mortality rates by weight category

Outcome
Normal weight
(BMI 18.5-24.9)
Overweight
(BMI 25-29.9)
Obesity 1
Obesity 2
Obesity 3
All deaths
68.39
71.16
84.47
102.85
116.85
CHD deaths
5.91
5.57
8.31
12.17
12.65

To download table as a slide, click on slide logo below

Extreme obesity was most common among black women (10% of the study population) and Native Americans (7.9%), and lowest among Asian and Pacific Islanders (1%). Across racial groups, obesity-related mortality and cardiovascular disease was mediated by diabetes, hypertension, and hyperlipidemia.

"The escalating prevalence of extreme obesity may exacerbate the health effects and health-related expenditures resulting from the US obesity epidemic," McTigue et al write. "Calculating the weight-related risks of morbidity and mortality based on findings in earlier population samples, which tended to reflect lower degrees of obesity, may underestimate the risks for extremely obese individuals and overestimate the risks for mildly obese individuals in diverse groups."

By taking into account the varying degree of risk associated with different categories of obesity, clinicians and policy-makers might be better able to tailor therapies and understand risk levels, they conclude.

Source
  1. McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006; 296:79-86.




You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Join theheart.org community
Five reasons to become a member of the most trusted source of cardiology news:
1Be part of the conversation in our blogs and discussion forum
2Share your thoughts on our news or educational programs
3Receive exclusive newsletters related to your field of interest
4Access unique continuous medical education content
5See and read what leaders have to say about cardiology today
It is free and it only takes five minutes to join!
 
button
Latest 5 articles from Lipid/Metabolic
Previews
Featured CME
Inside: Lipid/Metabolic
Lipid/Metabolic
Nov 10, 2008 10:55 EST
How can we better identify patients at risk of developing cardiovascular disease? Drs Davidson, Ginsberg, and Chapman provide the lowdown on strategies to identify and treat patients with mixed dyslipidemia and ensure they achieve all their target lipid levels.
Lipid/Metabolic
2 COMMENTS - Jul 14, 2008 09:28 EDT
When and how do you treat elevated triglycerides? Click to take the survey and immediately compare your answers with your colleagues. Your responses will guide us in our selection of topics for future CME programming.
Lipid/Metabolic
Sep 8, 2008 10:00 EDT
Navigating the SEAS: Join Drs Fitchett and Chan as they present their views on the latest controversial findings from clinical on treating aortic stenosis with statins alone or in combination with ezetimibe.